Aignostics news
15.11.2024
Aignostics takes home prize at The Spark German Digital Awards
29.10.2024
Aignostics Secures $34 Million Series B to Enhance Precision Medicine with AI
14.03.2024
Bayer and Aignostics to collaborate on next generation precision oncology
09.01.2024
Aignostics’ foundation model for histopathology takes the lead on key benchmarks
20.10.2023
Aignostics achieves ISO 13485 certification to support clinical research and diagnostics development
05.06.2023
Aignostics and Virchow Laboratories collaborate to offer AI-powered pathology in China
14.04.2023
Aignostics presenting new research and collaborations at AACR 2023
14.03.2023
We welcome Gerald Moeller as new member of our Board of Directors
06.03.2023
Aignostics wins €1.4 million ProFIT Funding
15.09.2022
Aignostics Raises €14 million Series A to Advance AI-powered Pathology
09.08.2022
Aignostics earns ISO 27001 certification for information security
09.03.2022
Aignostics & Ultivue Announce Unique Spatial AI-Powered Imaging Solutions for Translational Medicine
01.01.2022
We are appointing Jessica Riley as our new Chief Business Officer!
01.01.2022
We welcome Emmanuel Blin as our new Chairman of the Board!
01.01.2022
Aignostics closes €5m Seed Round
01.01.2022
Precise diagnostics with AI: BIH Digital Health Accelerator guides Aignostics GmbH through its spin-off
01.01.2022
Machine learning improves the diagnosis of patients with head and neck cancers
01.01.2022
Maschinelles Lernen in der Pathologie: Komplexe Daten sichtbar machen und interpretieren
01.01.2022
Die zwei Gesichter der intelligenten Assistenten
01.01.2022
Wenn ein Computer über die Therapie entscheidet
01.01.2022
Algorithmen werden die Pathologen nicht ersetzen
Home
Products
Products Overview
Our Foundation Model
Platform
Company
About us
Careers
Press
News
Publications
Company
Careers
Press
Partner Login
Contact
